ADMP - Adamis Pharmaceuticals Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts3333
Avg. Estimate-0.15-0.1-0.8-0.44
Low Estimate-0.16-0.15-0.83-0.67
High Estimate-0.14-0.01-0.78-0.06
Year Ago EPS-0.3-0.26-1.45-0.8
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts3333
Avg. Estimate4.27M6.16M14.56M27.53M
Low Estimate3.6M3.7M14M18M
High Estimate4.72M9.87M14.95M42.91M
Year Ago Sales2.47M3.04M6.47M14.56M
Sales Growth (year/est)72.90%102.80%124.90%89.10%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.24-0.2-0.13-0.16
EPS Actual-0.3-0.26-0.19-0.21
Difference-0.06-0.06-0.06-0.05
Surprise %-25.00%-30.00%-46.20%-31.20%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.15-0.1-0.8-0.44
7 Days Ago-0.15-0.1-0.8-0.44
30 Days Ago-0.15-0.07-0.8-0.32
60 Days Ago-0.15-0.07-0.8-0.32
90 Days Ago-0.15-0.08-0.79-0.35
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesADMPIndustrySectorS&P 500
Current Qtr.50.00%N/AN/A0.34
Next Qtr.61.50%N/AN/A0.40
Current Year44.80%N/AN/A0.17
Next Year45.00%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A